WELLINGTON MANAGEMENT GROUP LLP
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 902219
Boston, MA
Position in CRNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$266,845,159
-$29,424,487 QoQ
Shares Held
7,131,084
-12.6% QoQ
Ownership
6.72%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#4
of 264 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 88%
None 12%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. CRNX ranks #22 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in CRNX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $266,845,163 | 7,131,084 | Shares | Sole | 2026-08-13 | |
| 2026-06-30 | $266,845,159 | 7,131,084 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $296,269,646 | 8,157,204 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $374,163,729 | 8,037,889 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $349,109,921 | 8,381,991 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $167,018,174 | 5,807,308 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $231,137,453 | 6,891,397 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $355,382,485 | 6,950,567 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $227,890,206 | 4,459,691 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $206,948,293 | 4,620,413 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $139,099,749 | 2,971,582 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $115,460,833 | 3,245,105 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $108,260,585 | 3,640,235 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $64,902,849 | 3,601,712 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $58,386,546 | 3,635,526 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $51,322,074 | 2,804,485 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $51,712,335 | 2,633,011 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $34,010,102 | 1,823,598 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $22,594,538 | 1,029,364 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $30,406,426 | 1,070,272 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $19,220,144 | 913,071 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $14,050,543 | 745,387 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $8,437,110 | 552,167 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $7,854,119 | 556,635 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,859,636 | 437,756 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $5,453,643 | 311,281 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||